# Seqirus Inc – FDA Inspection, Jun 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/seqirus-inc/4027549a-c56f-482f-8f8f-d3fe1419260f
Source feed: FDA_Inspections

> FDA inspection 1061837 of Seqirus Inc, June 18, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061837
- Company Name: Seqirus Inc
- Inspection Date: 2018-06-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1271769 - 2025-06-05](https://www.keypedia.com/records/fda_inspections/seqirus-inc/537b3437-a5d5-4d50-acfe-d5c5f30582d9)
- FDA Inspection 1172982 - 2022-06-09
- FDA Inspection 968013 - 2016-05-17
- FDA Inspection 860576 - 2013-11-21

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/haruhiko-murata/8e16e91c-7831-4519-8d5f-1c74f4485332)
- [FDA Associated Person](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108)

Company: https://www.keypedia.com/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d